Neuropsychological test battery in the follow-up of patients with juvenile neuronal ceroid lipofuscinosis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Intellectual Disability Research

• Publication date

  2001-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/J.1365-2788.2001.00288.XPMID 11168772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intolerance to diphenylhydantoin in five cases of Vogt-Spielmeyer disease.

  2008cited by this paper
• Neuronal ceroid lipofuscinoses in childhood

  2000cited by this paper
• Sleep alterations in juvenile neuronal ceroid-lipofuscinosis.

  2000cited by this paper
• Clinical and magnetic resonance imaging findings in batten disease: Analysis of the major mutation (1.02‐kb deletion)

  1997cited by this paper
• Qualitative MRI Segmentation in Mesial Temporal Sclerosis: Clinical Correlations

  1996cited by this paper
• Neuroimaging in Pediatric Epilepsy

  1996cited by this paper
• Prenatal diagnosis of Batten's disease.

  1996cited by this paper
• MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis.

  1996cited by this paper
• Brain perfusion SPECT in juvenile neuronal ceroid lipofuscinosis.

  1996cited by this paper
• Rapid diagnostic test for the major mutation underlying Batten disease.

  1996cited by this paper
• Free radicals, anticonvulsants, and the neuronal ceroid-lipofuscinoses.

  1995cited by this paper
• Spielmeyer-Vogt (Batten, Spielmeyer-Sjögren) disease. Distinctive patterns of cerebral glucose utilization.

  1994cited by this paper
• Psychological symptoms and sleep disturbances in neuronal ceroid-lipofuscinoses (NCL)

  1993cited by this paper
• Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16.

  1990cited by this paper
• Neuronal ceroid-lipofuscinoses in childhood.

  1988cited by this paper
• Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease.

  1988cited by this paper
• C-band polymorphism: comparison between trisomy 21 cases and mentally retarded controls.

  1980cited by this paper
• Experience of Antioxidant Treatment in Neuronal Ceroid-Lipofuscinosis of Spielmeyer-Sjögren Type1

  1977cited by this paper
• A Clinical and Psychological Investigation into Juvenile Amaurotic Idiocy in Denmark

  1973cited by this paper

• A timeline of symptom onset and disease progression in CLN3 disease

  2025cites this paper
• The Wechsler intelligence scale for children, fourth and fifth editions perform comparably in children with Batten disease

  2025cites this paper
• The Wechsler Intelligence Scale for Children, fourth and fifth editions perform comparably in children with Batten Disease

  2025cites this paper
• Speech, Language and Non‐verbal Communication in CLN2 and CLN3 Batten Disease

  2025cites this paper
• Syndromic Retinitis Pigmentosa.

  2024cites this paper
• Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN)

  2024cites this paper
• Overlap between ophthalmology and psychiatry - A narrative review focused on congenital and inherited conditions.

  2023cites this paper
• Brain proton MR spectroscopy measurements in CLN3 disease.

  2023cites this paper
• Developmental Skills and Neurorehabilitation for Children With Batten Disease: A Retrospective Chart Review of a Comprehensive Batten Clinic.

  2023cites this paper
• Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): An auditory evoked potential study of the duration-evoked mismatch negativity (MMN)

  2023cites this paper
• A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes

  2022cites this paper
• Differential gene expression analysis following olfactory learning in honeybee (Apis mellifera L.)

  2022cites this paper
• Characterizing upper limb function in the context of activities of daily living in CLN3 disease

  2021influential citation
• Use of the Vineland‐3, a measure of adaptive functioning, in CLN3

  2021influential citation
• 16- Overview of advances in educational and social supports for young persons with NCL disorders.

  2020cites this paper
• Motor function impairment is an early sign of CLN3 disease

  2019cites this paper
• Neuronal ceroid-lipofuscinoses

  2018cites this paper
• Timing of cognitive decline in CLN3 disease

  2018cites this paper
• Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).

  2017cites this paper
• Identification of genetic interactions in a S. pombe yeast model for juvenile CLN3 disease

  2016cites this paper
• Schizophrenia and human self-domestication: an evolutionary linguistics approach

  2016cites this paper
• Juvenile NCL (CLN3 Disease): Emerging Disease-Modifying Therapeutic Strategies.

  2016cites this paper
• Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights

  2016cites this paper
• Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.

  2014cites this paper
• CLN5 deficiency results in alterations in the activation of autophagy

  2014cites this paper
• CLN5 DEFICIENCY RESULTS IN ALTERATIONS IN THE ACTIVATION OF AUTOPHAGY by THEODORE BUDDEN

  2014cites this paper
• Juvenile neuronal ceroid lipofuscinosis and education.

  2013cites this paper
• Neurobehavioral Features and Natural History of Juvenile Neuronal Ceroid Lipofuscinosis (Batten Disease)

  2013cites this paper
• Molecular Interactions of Neuronal Ceroid Lipofuscinosis Protein CLN3 [dissertaion]

  2012cites this paper
• A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.

  2011cites this paper
• INTERMITTENT PREDNISOLONE AND AUTOANTIBODIES TO GAD65 IN JUVENILE NEURONAL CEROID LIPOFUSCINOSIS

  2008cites this paper
• Neuropsychological Symptoms of Juvenile-Onset Batten Disease: Experiences From 2 Studies

  2007cites this paper
• Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update.

  2007cites this paper
• Dimensions of Attention and Executive Functioning in 5-To 12-Years-Old Children: Neuropsychological Assessment with the Nepsy Battery

  2007cites this paper
• The Color Object Association Test (COAT): The Development of a New Measure of Declarative Memory for 18- to 36-Month-Old Toddlers

  2007cites this paper
• Teach and Be Taught

  2006cites this paper
• Diagnosis of the neuronal ceroid lipofuscinoses: an update.

  2006cites this paper
• Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis.

  2005cites this paper
• A clinical rating scale for Batten disease

  2005cites this paper
• Pirkko Santavuori (1933-2004)

  2004cites this paper
• Validation of a Developmental Neuropsychological Assessment (NEPSY) through comparison of neurological, scholastic concerns, and control groups.

  2004cites this paper
• The Finnish disease heritage III: the individual diseases

  2003cites this paper
• Neurodegenerative disease: the neuronal ceroid lipofuscinoses (Batten disease)

  2001cites this paper
• Degenerative Neurological and Neuromuscular Disease Dovepress

  year unknowncites this paper
• Degenerative Neurological and Neuromuscular Disease Dovepress

  year unknowncites this paper